S2-E24.2 - From The Fourth Global NASH Congress -- How Treatment WIll Evolve Over The Next Several Years

Send us a text

After having time to think, six of the panelists who covered sessions at the Fourth Global NASH Congress get together one more time to consider key takeaways from the Congress. This conversation is organized around adoption of non-invasive testing in clinical development and when drugs will come to market.

After hearing presentations from 43 speakers at the Fourth Global NASH Congress, six SurfingNASH panelists convene once more to debate how long it will take before we have new medicines to use in identifying and treating patients. This is related to the question of when FDA and EMEA will accept non-invasive tests in pivotal trials. There was some disagreement on the year in which events will happen, but not on the basic pattern of market evolution.